Cover Image
市場調查報告書

生物標記技術的全球市場的預測 ∼2022年:層析法、NGS、PCR、質譜分析、免疫檢測、液態切片 (ddPCR、DHPLC)

Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 635156
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
生物標記技術的全球市場的預測 ∼2022年:層析法、NGS、PCR、質譜分析、免疫檢測、液態切片 (ddPCR、DHPLC) Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application - Global Forecast to 2022
出版日期: 2018年05月07日 內容資訊: 英文 130 Pages
簡介

全球生物標記技術的市場在預測期間內預計以9.7%的年複合成長率發展,從2017年的469億7000萬美元,成長到2022年的745億1000萬美元的規模。醫療費的增加和R&D資金的增加,診斷用途上的生物標記利用的擴大,生物標記研究的新倡議等的要素促進該市場的成長。

本報告提供全球生物標記技術的市場調查,市場定義和概要,市場成長的影響因素及市場機會分析,檢驗類型、用途、技術、產品等各種區分的趨勢與市場規模的變化與預測,市場佔有率分析等彙整資料。

第1章 簡介

第2章 調查手法

第3章 生物標記技術市場分析、預測:各檢驗類型

  • 簡介
  • 固體切片檢查
  • 液態切片

第4章 液態切片用生物標記市場分析、預測:各用途

  • 簡介
  • 臨床診斷
  • 研究
  • 藥物研發、開發

第5章 液態切片市場分析、預測:各技術

  • DDPCR
  • NGS
  • 質譜分析
  • DHPLC
  • 其他

第6章 生物標記技術市場分析、預測:各產品

  • 消耗品
  • 設備
  • 服務
  • 軟體/資訊學

第7章 生物標記產品市場分析、預測:各用途

  • 消耗品
    • 診斷
      • 臨床利用
      • 研究
    • 藥物研發、開發
  • 設備
    • 診斷
      • 臨床利用
      • 研究
    • 藥物研發、開發
  • 服務
    • 診斷
      • 臨床利用
      • 研究
    • 藥物研發、開發
  • 軟體/資訊學
    • 診斷
      • 臨床利用
      • 研究
    • 藥物研發、開發

第8章 生物標記技術市場分析、預測:各分析技術

  • 免疫檢測
    • ELISA
    • 西方印漬術
    • 蛋白質微陣列
  • PCR
  • 質譜分析
  • NGS
  • 層析法
  • 影像技術
  • 細胞遺傳學
  • 其他

第9章 生物標記分析技術市場分析、預測:各用途

  • 免疫檢測
  • PCR
  • 質譜分析
  • NGS
  • 影像技術
  • 細胞遺傳學
  • 其他
    • 臨床診斷
    • 研究
    • 藥物研發、開發

第10章 生物標記市場分析、預測:各疾病區分、用途

  • 癌症
  • 感染疾病
  • 自體免疫疾病
  • 神經系統疾病
  • 心臟血管疾病
  • 其他
    • 診斷
      • 臨床利用
      • 研究
    • 藥物研發、開發

第11章 生物標記技術市場分析、預測:各用途

  • 生物標記的鑑定、驗證、開發、研究
  • 生物標記為基礎的例行性試驗

第12章 生物標記技術市場分析、預測:各用途、產品

  • 生物標記的鑑定、驗證、開發、研究
  • 生物標記為基礎的例行性試驗
    • 消耗品
    • 設備
    • 服務
    • 軟體

第13章 生物標記技術市場分析、預測:各研究領域

  • 基因學
  • 蛋白質體學
  • 代謝體學
  • 其他

第14章 市場佔有率分析

  • 質譜分析
  • 層析法

第15章 生物標記技術市場分析、預測:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他
目錄
Product Code: MD 6249

"The biomarker technologies market is projected to grow at a CAGR of 9.7%."

The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period

The growth of this market is mainly driven by increasing healthcare expenditure and the increase in R&D funding. Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research. Moreover, the emergence of companion diagnostics (CDx) has further intensified biomarker R&D activities. However, significant capital investments are required for the discovery, development, and validation of biomarkers. This is a major factor restraining the growth of the biomarker technologies market.

Immunoassays held the largest share of the biomarker technologies market, by profiling technology, in 2017.

Based on profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share of the market. This segment is further divided into the ELISA, western blot, and protein microarray segment. The protein microarray segment is expected to grow at the fastest pace during the forecast period, mainly due to its increasing use in drug discovery. Moreover, it reduces the time taken, costs, and reagent consumption. This market is driven by advances in the field of proteomics and improvements in the field of recombinant proteins.

Genomics held the largest share of the biomarker technologies market, by research area, in 2017

Based on research area, this market is classified into genomics, proteomics, metabolomics, and other research areas. The focus on biomarker research in the field of genomics is growing with the advent of innovative technologies such as NGS, microarrays, and dPCR; this is supporting market growth.

Cancer was estimated to dominate the biomarker technologies market, by disease indication, in 2017

Based on disease indication, the biomarker technologies market is classified into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer accounted for the largest share of the biomarker technologies market, as biomarkers have major applications in cancer research, diagnostics, and treatment.

Break-up profile of primaries::

  • By Company Type: Tier 1-42%, Tier 2-37%, and Tier 3-21%.
  • By Designation: C-level-34%, D-level-42%, and Others-24%
  • By Region: North America-32%, Europe-30%, Asia-24%, and RoW-14%

The key players in this market are: Agilent Technologies (US), Thermo Fisher Scientific (US), Roche (Switzerland), Waters Corporation (US), Danaher Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).

Research Coverage:

In this report, the biomarker technologies market is segmented by test type, product, application, profiling technology, disease indication, system, and research type. Specific segments have also been studied based on application-clinical diagnostics, drug discovery & development, and applied research. The biomarker systems market has also been classified based on products used.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the portfolios of the top players in the biomarker technologies market. The report analyzes the market by test type, product, application, profiling technology, disease indication, system, research type, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the biomarker technologies market.
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for biomarker technologies market products across regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the biomarker technologies market.
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of key players in the biomarker technologies market for mass spectrometry and chromatography.

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. BIOMARKER TECHNOLOGIES MARKET, BY TEST TYPE

  • 3.1. INTRODUCTION
  • 3.2. SOLID BIOPSY
  • 3.3. LIQUID BIOPSY

4. BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION

  • 4.1. INTRODUCTION
  • 4.2. CLINICAL DIAGNOSTICS
  • 4.3. RESEARCH
  • 4.4. DRUG DISCOVERY AND DEVELOPMENT

5. LIQUID BIOPSY MARKET, BY TECHNOLOGY

  • 5.1. DDPCR
  • 5.2. NGS
  • 5.3. MASS SPECTROMETRY
  • 5.4. DHPLC
  • 5.5. OTHER

6. BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT

  • 6.1. CONSUMABLES
  • 6.2. INSTRUMENTS
  • 6.3. SERVICES
  • 6.4. SOFTWARE/INFORMATICS

7. BIOMARKER PRODUCT MARKET, BY APPLICATION

  • 7.1. CONSUMABLES
    • 7.1.1. DIAGNOSTICS
      • 7.1.1.1. CLINICAL USE
      • 7.1.1.2. RESEARCH
    • 7.1.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.2. INSTRUMENTS
    • 7.2.1. DIAGNOSTICS
      • 7.2.1.1. CLINICAL USE
      • 7.2.1.2. RESEARCH
    • 7.2.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.3. SERVICES
    • 7.3.1. DIAGNOSTICS
      • 7.3.1.1. CLINICAL USE
      • 7.3.1.2. RESEARCH
    • 7.3.2. DRUG DISCOVERY & DEVELOPMENT
  • 7.4. SOFTWARE/INFORMATICS
    • 7.4.1. DIAGNOSTICS
      • 7.4.1.1. CLINICAL USE
      • 7.4.1.2. RESEARCH
    • 7.4.2. DRUG DISCOVERY & DEVELOPMENT

8. BIOMARKER TECHNOLOGIES MARKET, BY PROFILING TECHNOLOGY

  • 8.1. IMMUNOASSAY
    • 8.1.1. ELISA
    • 8.1.2. WESTERN BLOT
    • 8.1.3. PROTEIN MICROARRAY
  • 8.2. PCR
  • 8.3. MASS SPECTROMETRY
  • 8.4. NGS
  • 8.5. CHROMATOGRAPHY
  • 8.6. IMAGING TECHNOLOGIES
  • 8.7. CYTOGENETICS
  • 8.8. OTHERS

9. BIOMARKER PROFILING TECHNOLOGY MARKET, BY APPLICATION

  • 9.1. IMMUNOASSAY
    • 9.1.1. CLINICAL DIAGNOSTICS
    • 9.1.2. RESEARCH
    • 9.1.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.2. PCR
    • 9.2.1. CLINICAL DIAGNOSTICS
    • 9.2.2. RESEARCH
    • 9.2.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.3. MASS SPECTROMETRY
    • 9.3.1. CLINICAL DIAGNOSTICS
    • 9.3.2. RESEARCH
    • 9.3.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.4. NGS
    • 9.4.1. CLINICAL DIAGNOSTICS
    • 9.4.2. RESEARCH
    • 9.4.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.5. IMAGING TECHNOLOGIES
    • 9.5.1. CLINICAL DIAGNOSTICS
    • 9.5.2. RESEARCH
    • 9.5.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.6. CYTOGENETICS
    • 9.6.1. CLINICAL DIAGNOSTICS
    • 9.6.2. RESEARCH
    • 9.6.3. DRUG DISCOVERY AND DEVELOPMENT
  • 9.7. OTHERS
    • 9.7.1. CLINICAL DIAGNOSTICS
    • 9.7.2. RESEARCH
    • 9.7.3. DRUG DISCOVERY AND DEVELOPMENT

10. BIOMARKER DISEASE INDICATION MARKET, BY APPLICATION

  • 10.1. CANCER
    • 10.1.1. DIAGNOSTICS
      • 10.1.1.1. CLINICAL USE
      • 10.1.1.2. RESEARCH
    • 10.1.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.2. INFECTIOUS DISEASES
    • 10.2.1. DIAGNOSTICS
      • 10.2.1.1. CLINICAL USE
      • 10.2.1.2. RESEARCH
    • 10.2.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.3. AUTOIMMUNE DISORDERS
    • 10.3.1. DIAGNOSTICS
      • 10.3.1.1. CLINICAL USE
      • 10.3.1.2. RESEARCH
    • 10.3.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.4. NEUROLOGICAL DISORDERS
    • 10.4.1. DIAGNOSTICS
      • 10.4.1.1. CLINICAL USE
      • 10.4.1.2. RESEARCH
    • 10.4.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.5. CARDIOVASCULAR DISORDERS
    • 10.5.1. DIAGNOSTICS
      • 10.5.1.1. CLINICAL USE
      • 10.5.1.2. RESEARCH
    • 10.5.2. DRUG DISCOVERY & DEVELOPMENT
  • 10.6. OTHER
    • 10.6.1. DIAGNOSTICS
      • 10.6.1.1. CLINICAL USE
      • 10.6.1.2. RESEARCH
    • 10.6.2. DRUG DISCOVERY & DEVELOPMENT

11. BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION

  • 11.1. BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH
  • 11.2. ROUTINE BIOMARKER-BASED TESTS

12. BIOMARKER TECHNOLOGY APPLICATIONS MARKET, BY PRODUCT

  • 12.1. BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH
    • 12.1.1. CONSUMABLES
    • 12.1.2. INSTRUMENTS
    • 12.1.3. SERVICES
    • 12.1.3. SOFTWARE
  • 12.2. ROUTINE BIOMARKER-BASED TESTS
    • 12.2.1. CONSUMABLES
    • 12.2.2. INSTRUMENTS
    • 12.2.3. SERVICES
    • 12.2.3. SOFTWARE

13. BIOMARKER TECHNOLOGIES MARKET, BY RESEARCH AREA

  • 13.1. GENOMICS
  • 13.2. PROTEOMICS
  • 13.3. METABOLOMICS
    • 13.3.1. METABOLIC FLUX
    • 13.3.2. LIPIDOMICS
    • 13.3.3. OTHERS
  • 13.4. OTHER RESEARCH TYPES

14. MARKET SHARE ANALYSIS

  • 14.1. BIOMARKER TECHNOLOGIES MARKET FOR MASS SPECTROMETRY: MARKET SHARE ANALYSIS
  • 14.2. BIOMARKER TECHNOLOGIES MARKET FOR CHROMATOGRAPHY: MARKET SHARE ANALYSIS

15. BIOMARKER TECHNOLOGIES MARKET, BY REGION

  • 15.1. NORTH AMERICA
    • 15.1.1. US
    • 15.1.2. CANADA
  • 15.2. EUROPE
  • 15.3. ASIA PACIFIC
  • 15.4. ROW

LIST OF TABLES

  • TABLE 1: GLOBAL BIOMARKERS TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 2: NORTH AMERICA: BIOMARKERS TESTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 3: GLOBAL BIOMARKERS MARKET, BY TEST TYPE, 2015-2022 (USD BILLION)
  • TABLE 4: GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 5: GLOBAL BIOMARKERS LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2017-2022 (USD BILLION)
  • TABLE 6: GLOBAL BIOMARKERS MARKET, BY PRODUCT, 2015-2022 (USD BILLION)
  • TABLE 7: GLOBAL BIOMARKERS CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 8: GLOBAL BIOMARKERS PRODUCTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 9: NORTH AMERICA: BIOMARKERS PRODUCTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 10: GLOBAL CONSUMABLES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 11: GLOBAL REAGENTS & KITS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 12: NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 13: GLOBAL CHROMATOGRAPHY COLUMNS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 14: GLOBAL INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 15: NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 16: GLOBAL SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 17: NORTH AMERICA: SERVICES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 18: GLOBAL SOFTWARE/INFORMATICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 19: NORTH AMERICA: SOFTWARE/INFORMATICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 20: GLOBAL CONSUMABLES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 21: GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 22: GLOBAL CONSUMABLES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 23: GLOBAL CONSUMABLES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 24: GLOBAL INSTRUMENTS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 25: GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 26: GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 27: GLOBAL INSTRUMENTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 28: GLOBAL SERVICES MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 29: GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 30: GLOBAL SERVICES MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 31: GLOBAL SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 32: GLOBAL SOFTWARE/INFORMATICS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 33: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 34: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 35: GLOBAL SOFTWARE/INFORMATICS MARKET FOR DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 36: GLOBAL BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015-2022 (USD BILLION)
  • TABLE 37: GLOBAL BIOMARKERS MARKET FOR IMMUNOASSAYS, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 38: GLOBAL BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 39: NORTH AMERICA: BIOMARKERS MARKET FOR PROFILING TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 40: GLOBAL IMMUNOASSAYS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 41: GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 42: NORTH AMERICA: IMMUNOASSAYS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 43: GLOBAL ELISA MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 44: GLOBAL WESTERN BLOT MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 45: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 46: NORTH AMERICA: WESTERN BLOT MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 47: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 48: KEY EVOLUTIONARY MILESTONES IN THE FIELD OF QPCR/DPCR
  • TABLE 49: GLOBAL PCR MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 50: NORTH AMERICA: PCR MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 51: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 52: NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 53: LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS DURING 2015-2017
  • TABLE 54: GLOBAL NGS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 55: NORTH AMERICA: NGS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 56: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 57: NORTH AMERICA: CHROMATOGRAPHY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 58: GLOBAL IMAGING TECHNOLOGY MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 59: GLOBAL CYTOGENETICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 60: NORTH AMERICA: IMAGING TECHNOLOGY MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 61: NORTH AMERICA: CYTOGENETICS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 62: GLOBAL BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 63: NORTH AMERICA: BIOMARKERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 64: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMMUNOASSAY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 65: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR PCR, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 66: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR MASS SPECTROMETRY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 67: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR NGS, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 68: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR IMAGING TECHNOLOGY, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 69: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR CYTOGENETICS, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 70: GLOBAL BIOMARKER PROFILING TECHNOLOGY MARKET FOR OTHER TECHNOLOGIES, BY APPLICATION, 2017-2022 (USD BILLION)
  • TABLE 71: GLOBAL BIOMARKERS MARKET, BY DISEASE INDICATION, 2015-2022 (USD BILLION)
  • TABLE 72: GLOBAL CANCER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 73: NORTH AMERICA: CANCER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 74: GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 75: GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 76: GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 77: GLOBAL CANCER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 78: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 79: NORTH AMERICA: INFECTIOUS DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 80: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 81: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 82: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 83: GLOBAL INFECTIOUS DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 84: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 85: NORTH AMERICA: AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 86: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 87: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 88: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 89: GLOBAL AUTOIMMUNE DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 90: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 91: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 92: NORTH AMERICA: NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 93: GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 94: GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 95: GLOBAL DEGENERATIVE DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 96: GLOBAL OTHER NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 97: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 98: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 99: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 100: GLOBAL NEUROLOGICAL DISORDER BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 101: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 102: NORTH AMERICA: CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 103: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 104: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 105: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 106: GLOBAL CARDIOVASCULAR DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 107: GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 108: NORTH AMERICA: OTHER DISEASE BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD BILLION)
  • TABLE 109: GLOBAL OTHER DISEASE BIOMARKERS MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 110: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 111: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DIAGNOSTICS, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 112: GLOBAL OTHER DISEASE BIOMARKERS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 113: GLOBAL BIOMARKERS MARKET, BY SYSTEM, 2015-2022 (USD BILLION)
  • TABLE 114: GLOBAL BIOMARKER IDENTIFICATION, VALIDATION & DEVELOPMENT RESEARCH MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 115: GLOBAL ROUTINE BIOMARKER-BASED TESTS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 116: BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH, BY PRODUCT, 2017-2022 (USD BILLION)
  • TABLE 117: ROUTINE BIOMARKER BASED TEST / ASSAYS FOR CLINICAL USE, BY PRODUCT, 2017-2022 (USD BILLION)
  • TABLE 118: GLOBAL BIOMARKERS MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
  • TABLE 119: GLOBAL BIOMARKER IDENTIFICATION, VALIDATION AND DEVELOPMENT RESEARCH MARKET, BY RESEARCH TYPE, 2015-2022 (USD BILLION)
  • TABLE 120: GLOBAL GENOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 121: GLOBAL PROTEOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 122: GLOBAL METABOLOMICS MARKET, BY TYPE, 2015-2022 (USD BILLION)
  • TABLE 123: GLOBAL METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 124: GLOBAL LIPIDOMICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 125: GLOBAL METABOLIC FLUX MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 126: GLOBAL OTHER METABOLOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 127: GLOBAL MICROBIOME MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 128: GLOBAL OTHER RESEARCH TYPES MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 129: STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
  • TABLE 130: BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
  • TABLE 131: STRENGTH OF PRODUCT PORTFOLIO (KEY PLAYERS)
  • TABLE 132: BUSINESS STRATEGY EXCELLENCE (KEY PLAYERS)
  • TABLE 133: GLOBAL BIOMARKER MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 134: NORTH AMERICA: BIOMARKER MARKET, BY COUNTRY, 2015-2022 (USD BILLION)

LIST OF FIGURES

  • FIGURE 1: PARADIGM SHIFT: RX TO CDX
  • FIGURE 2: BIOMARKER DISCOVERY: TRADITIONAL VS. CONVENTIONAL
  • FIGURE 3: NUMBER OF PUBLICATIONS USING MALDI MSI
  • FIGURE 4: PROTEOMICS APPROACH: AUTOIMMUNE DISEASE BIOMARKER DISCOVERY
  • FIGURE 5: METABOLOMICS PLATFORM SHOWING FLOW OF INFORMATION OF METABOLITES
  • FIGURE 6: GLOBAL BIOMARKERS MARKET FOR MASS SPECTROMETRY: MARKET SHARE ANALYSIS, BY KEY PLAYER
  • FIGURE 7: GLOBAL BIOMARKERS MARKET FOR CHROMATOGRAPHY: MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017
Back to Top